Company intelligence / Profile preview

South Coast Specialty Compounding

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

South Coast Specialty Compounding operated as a sterile compounding pharmacy licensed in California, primarily producing compounded drugs and sterile injectables for direct patient use. FDA issued observations and a warning letter regarding deficiencies in sterile processing and sanitation during inspections in 2014, 2015, and 2016. On June 1, 2016, the business began operating as Imprimis Pharmaceuticals, Inc.

Modalities: Small moleculecompounded sterile preparations
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on South Coast Specialty Compounding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on South Coast Specialty Compounding.

Explore the full profile